Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
0.640
-0.525 (-45.03%)
At close: Jul 1, 2022 4:00 PM
0.628
-0.012 (-1.921%)
After-hours: Jul 1, 2022 7:59 PM EDT

Stock Price Forecast

According to 8 stock analysts, the average 12-month stock price forecast for AGRX stock is $102, which predicts an increase of 15827.55%. The lowest target is $101 and the highest is $105. On average, analysts rate AGRX stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $101 $102 $102 $105
Change +15671.4% +15827.5% +15827.5% +16296.0%

Analyst Ratings

The average analyst rating for AGRX stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 333332
Buy 555544
Hold 111122
Sell 000000
Strong Sell 000000
Total 999998

Financial Forecast

Revenue This Year
9.46M
Increased by 130.68%
Revenue Next Year
38.93M
Increased by 311.57%
EPS This Year
-17.14
EPS Next Year
-6.53
Year 2017201820192020202120222023202420252026
Revenue
---749.00K4.10M9.46M38.93M77.89M190.90M477.25M
Revenue Growth
----
447.53%
130.68%
311.57%
100.05%
145.10%
150.00%
EPS
-36.40-23.20-15.20-24.40-30.80-17.14-6.532.861.150.47
EPS Growth
--------
-59.88%
-59.08%
No. Analysts -----55511

Revenue Forecast

Revenue 20222023202420252026
High 10.7M 52.5M 105.0M 200.4M 496.3M
Avg 9.5M 38.9M 77.9M 190.9M 477.2M
Low 8.2M 25.8M 51.7M 185.2M 462.9M

Revenue Growth

Revenue Growth 20222023202420252026
High
155.9%
455.0%
169.7%
157.4%
160.0%
Avg
126.0%
311.6%
100.0%
145.1%
150.0%
Low
95.5%
172.9%
32.7%
137.7%
142.5%

EPS Forecast

EPS 20222023202420252026
High -17.64 -6.72 2.94 1.20 0.49
Avg -17.14 -6.53 2.86 1.15 0.47
Low -16.46 -6.27 2.74 1.11 0.45

EPS Growth

EPS Growth 20222023202420252026
High - - -
-57.9%
-57.4%
Avg - - -
-59.9%
-59.1%
Low - - -
-61.1%
-60.3%